Health and Fitness Health and Fitness
Wed, November 10, 2010
[ Wed, Nov 10th 2010 ] - Market Wire
Fibrocell Science, Inc. to Present at the Maxim Group Growth Conference
[ Wed, Nov 10th 2010 ] - Market Wire
Incyte to Host Webcast at 2010 ACR/ARHP Annual Scientific Meeting
[ Wed, Nov 10th 2010 ] - Market Wire
Forest Laboratories, Inc. Announces Executive Man .. ment of Lawrence Olanoff as President and Chief O
[ Wed, Nov 10th 2010 ] - Market Wire
Vertex Announces Plans to Enroll Additional Treat .. ombination Study of Telaprevir and VX-222 for the
[ Wed, Nov 10th 2010 ] - Market Wire
BELLUS HEALTH REPORTS RESULTS FOR THIRD QUARTER E .. NNOUNCES RECEIPT OF US$5 MILLION FROM PARTNER CEL
[ Wed, Nov 10th 2010 ] - Market Wire
ARIAD to Present at the Lazard Capital Markets 7th Annual Healthcare Conference
[ Wed, Nov 10th 2010 ] - Market Wire
Zalicus Reports Financial Results for the Third Quarter 2010
[ Wed, Nov 10th 2010 ] - Market Wire
Oncolytics Biotech® Inc. Announces Third Quarter 2010 Results
[ Wed, Nov 10th 2010 ] - Market Wire
Spectranetics to Present at the Citi Small/Mid Cap Conference on November 17
[ Wed, Nov 10th 2010 ] - Market Wire
AVEO to Present New Clinical Data Evaluating Tivo .. bination with FOLFOX6 at EORTC-NCI-AACR Symposium
[ Wed, Nov 10th 2010 ] - Market Wire
AngioDynamics to Participate at the Stephens Inc. Fall Investment Conference
[ Wed, Nov 10th 2010 ] - Market Wire
Cerus Corporation Prices Public Offering of Common Stock and Warrants
Tue, November 9, 2010
[ Tue, Nov 09th 2010 ] - Market Wire
IntegraMed® To Participate At The Lazard Capital .. s 7th Annual Healthcare Conference On November 16
[ Tue, Nov 09th 2010 ] - Market Wire
Health Net Sponsors American Veterans Disabled for Life Memorial
[ Tue, Nov 09th 2010 ] - Market Wire
Northstar Healthcare Reports 2010 Third Quarter Results
[ Tue, Nov 09th 2010 ] - Market Wire
BioScrip, Inc. to Present at Bank of America Merrill Lynch 2010 Credit Conference
[ Tue, Nov 09th 2010 ] - Market Wire
ISOTECHNIKA REPORTS THIRD QUARTER 2010 FINANCIAL RESULTS
[ Tue, Nov 09th 2010 ] - Market Wire
CENTRIC HEALTH RECEIVES FINANCING FROM MAJOR SHAREHOLDER FOR MERGERS &; ACQUISITIONS
[ Tue, Nov 09th 2010 ] - Market Wire
Inhibitex Reports Third Quarter Financial Results and Corporate Highlights
[ Tue, Nov 09th 2010 ] - Market Wire
Incyte Reports Third Quarter 2010 Financial Resul .. Update on Drug Discovery and Development Programs
[ Tue, Nov 09th 2010 ] - Market Wire
NeuroMetrix Reports Q3 2010 Financial Results Pro .. ss in New Sales Channel; Reduced Cash Consumption
[ Tue, Nov 09th 2010 ] - Market Wire
Spectral Molecular Imaging, Inc. Awarded Qualifyi .. ect Government Grant for its Melanoma Detection P
[ Tue, Nov 09th 2010 ] - Market Wire
Covidien presenta i risultati del quarto trimestre e dell'anno fiscale 2010
[ Tue, Nov 09th 2010 ] - Market Wire
SuperGen to Present at Lazard Healthcare Conference on November 16th
[ Tue, Nov 09th 2010 ] - Market Wire
Illumina to Present at Upcoming Investment Conferences in November
[ Tue, Nov 09th 2010 ] - Market Wire
GTx, Inc. Reports Third Quarter 2010 Corporate Results
[ Tue, Nov 09th 2010 ] - Market Wire
Community Health Systems to Participate in the Citi 7th Annual U.S. Small/Mid Cap Conference
[ Tue, Nov 09th 2010 ] - Market Wire
U.S. Physical Therapy to Present at the Wall Street Analyst Forum University Club of New York
[ Tue, Nov 09th 2010 ] - Market Wire
Covidien maakt resultaten vierde kwartaal en fiscaal jaar 2010 bekend
[ Tue, Nov 09th 2010 ] - Market Wire
Synta Pharmaceuticals to Present at the Lazard Capital Markets Annual Healthcare Conference

Synta Pharmaceuticals to Present at the Lazard Capital Markets Annual Healthcare Conference


Published on 2010-11-09 13:36:16 - Market Wire
  Print publication without navigation


LEXINGTON, Mass.--([ BUSINESS WIRE ])--Synta Pharmaceuticals Corp. (NASDAQ: SNTA), a biopharmaceutical company focused on discovering, developing, and commercializing small molecule drugs to treat severe medical conditions, today announced that the Company will be presenting at the Lazard Capital Markets 7th Annual Healthcare Conference on Tuesday, November 16 at 2:10 p.m. (ET) in New York.

A live audio webcast and replay of the presentation will be available at [ http://www.wsw.com/webcast/lz8/snta/ ].

About Synta Pharmaceuticals

Synta Pharmaceuticals Corp. is a biopharmaceutical company focused on discovering, developing, and commercializing small molecule drugs to extend and enhance the lives of patients with severe medical conditions, including cancer and chronic inflammatory diseases. Synta has a unique chemical compound library, an integrated discovery engine, and a diverse pipeline of clinical- and preclinical-stage drug candidates with distinct mechanisms of action and novel chemical structures. All Synta drug candidates were invented by Synta scientists using our compound library and discovery capabilities. For more information, please visit [ www.syntapharma.com ].

Contributing Sources